Evidence map›Paper›PMID 33935766›Full record

ArticleFrontiers in pharmacology2021

Methanolic Extract of

Parul Kamboj, Soumalya Sarkar, Sonu Kumar Gupta, Neema Bisht, Deepika Kumari, Md Jahangir Alam, Sagar Barge, Bhaswati Kashyap, Barsha Deka, Simanta Bharadwaj and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Beneficial Activities ofNutrients · 2022
    Article
  5. Frontiers in pharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Parul KambojNon-communicable Disease Group, Translational Health Science and Technology Institute (THSTI), Faridabad, India.
Soumalya SarkarNon-communicable Disease Group, Translational Health Science and Technology Institute (THSTI), Faridabad, India.
Sonu Kumar GuptaNon-communicable Disease Group, Translational Health Science and Technology Institute (THSTI), Faridabad, India.
Neema BishtNon-communicable Disease Group, Translational Health Science and Technology Institute (THSTI), Faridabad, India.
Deepika KumariNon-communicable Disease Group, Translational Health Science and Technology Institute (THSTI), Faridabad, India.
Md Jahangir AlamDepartment of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, India.
Sagar BargeInstitute of Advanced Study in Science and Technology (IASST), Guwahati, India.
Bhaswati KashyapInstitute of Advanced Study in Science and Technology (IASST), Guwahati, India.
Barsha DekaInstitute of Advanced Study in Science and Technology (IASST), Guwahati, India.
Simanta BharadwajInstitute of Advanced Study in Science and Technology (IASST), Guwahati, India.
Seydur RahmanInstitute of Advanced Study in Science and Technology (IASST), Guwahati, India.
Partha Pratim DuttaInstitute of Advanced Study in Science and Technology (IASST), Guwahati, India.
Jagat C BorahInstitute of Advanced Study in Science and Technology (IASST), Guwahati, India.
Narayan Chandra TalukdarInstitute of Advanced Study in Science and Technology (IASST), Guwahati, India.
Sanjay K BanerjeeNon-communicable Disease Group, Translational Health Science and Technology Institute (THSTI), Faridabad, India.
Yashwant KumarNon-communicable Disease Group, Translational Health Science and Technology Institute (THSTI), Faridabad, India.
Institute of Advanced Study in Science and Technology · INTranslational Health Science and Technology Institute · INNational Institute of Pharmaceutical Education and Research · INAssam Down Town University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fatty liver is one of the most common metabolic syndrome affecting the global population. Presently, limited treatment modalities with symptomatic approach are available for alleviating fatty liver. Traditional and herbal treatment modalities have shown evidence to improve the disease pathology. In the present research work, evaluation of a selected medicinal plant

Indexed as

animal modelbile acidsfatty acidsherbal extractLC-MS/MSPPARα

Identifiers

PMID33935766
PMCPMC8082144
OpenAlexW3156129238

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.